UPDATED: Celgene bags CAR-T player Juno in $9B buyout as biotech M&A suddenly explodes – Endpoints News
Endpoints News |
UPDATED: Celgene bags CAR–T player Juno in $9B buyout as biotech M&A suddenly explodes
Endpoints News Leerink in particular was looking for Celgene to fork over $93 a share, which is what Celgene pegged the price at when it bought a minority share in the biotech. CAR-T has been one of the big success stories for biotech, offering a new approach to … Muscle CAR? Celgene's $9B offer for Juno starts pundits weighing traction Celgene to buy Juno for $9 billion to boost cancer pipeline Shares of biotech Juno, already up 50% on deal hopes, skyrocket on actual Celgene $9 billion offer |
